Cargando…

COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase

Detalles Bibliográficos
Autores principales:	Halstead, Scott B., Akkina, Ramesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272599/ https://www.ncbi.nlm.nih.gov/pubmed/32574267 http://dx.doi.org/10.3389/fimmu.2020.01196

Ejemplares similares

Ultra-Sensitive HIV-1 Latency Viral Outgrowth Assays Using Humanized Mice
por: Schmitt, Kimberly, et al.
Publicado: (2018)

Editorial: Development of Humanized Mouse Models for Infectious Diseases and Cancer
por: Tsuji, Moriya, et al.
Publicado: (2020)

Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19
por: Jörrißen, Philipp, et al.
Publicado: (2021)

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: de Miranda Santos, Isabel Kinney Ferreira, et al.
Publicado: (2020)

Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: Santos, Isabel Kinney Ferreira De Miranda, et al.
Publicado: (2020)

Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus
por: Shang, Yufeng, et al.
Publicado: (2021)

Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
por: Konwarh, Rocktotpal
Publicado: (2020)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
por: de Souza, Matheus Oliveira, et al.
Publicado: (2022)

SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients
por: Lin, Frank J., et al.
Publicado: (2022)

Zika virus induced microcephaly and aberrant hematopoietic cell differentiation modeled in novel neonatal humanized mice
por: Schmitt, Kimberly, et al.
Publicado: (2023)

Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray
por: Hosseinian, Sina, et al.
Publicado: (2022)

SARS-CoV-2 Testing of the Maxillary Sinus Immediately after COVID-19 Recovery
por: Maeba, Takahiro, et al.
Publicado: (2023)

Protective Immune Responses to Dengue Virus Infection and Vaccines: Perspectives from the Field to the Bench
por: Halstead, Scott B., et al.
Publicado: (2015)

Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease
por: Brynjolfsson, Siggeir F., et al.
Publicado: (2021)

Coronavirus Disease (COVID-19–SARS-CoV-2) and Nutrition: Is Infection in Italy Suggesting a Connection?
por: Cena, Hellas, et al.
Publicado: (2020)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients
por: Greenbaum, Uri, et al.
Publicado: (2021)

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
por: Steiner, Sophie, et al.
Publicado: (2021)

Erratum: Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease
Publicado: (2021)

Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option
por: Stahel, Philip F., et al.
Publicado: (2020)

Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide
por: Vanderheijden, Nathalie, et al.
Publicado: (2022)

Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection
por: Yuen, Rachel R., et al.
Publicado: (2021)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
por: Dalakas, Marinos C., et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients
por: Ferré, Elise M. N., et al.
Publicado: (2021)

COVID-19: Coronavirus Vaccine Development Updates
por: Zhao, Jing, et al.
Publicado: (2020)

Durability and extent of protection of SARS-CoV-2 antibodies among patients with COVID-19 in Metro Manila, Philippines
por: Gonzales, Ma. Liza Antoinette M., et al.
Publicado: (2023)

Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003
por: Tseng, Wen-Pin, et al.
Publicado: (2021)

Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study
por: Sánchez García, Laura, et al.
Publicado: (2021)

Legionella pneumonia immediately after recovery from COVID‐19
por: Jingu, Daisuke, et al.
Publicado: (2022)

COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2
por: Kumar, Nitya, et al.
Publicado: (2022)

Bovine Coronavirus Immune Milk Against COVID-19
por: Arenas, Antonio, et al.
Publicado: (2021)

Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography
por: Wang, Jiong, et al.
Publicado: (2021)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies
por: Pace, Ryan M., et al.
Publicado: (2021)

Memory SARS-CoV-2 T-cell response in convalescent COVID-19 patients with undetectable specific IgG antibodies: a comparative study
por: Fernández-Moreno, Raquel, et al.
Publicado: (2023)

Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
por: Lin, Yajie, et al.
Publicado: (2022)

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
por: Rosati, Margherita, et al.
Publicado: (2021)

SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry
por: Matveeva, Olga, et al.
Publicado: (2022)

Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents
por: Wang, Zheng, et al.
Publicado: (2023)

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dh356q70dp5amhlikadtdl7kt4